- Home
- MSPR vs EVGN Comparison
MSPR vs EVGN Comparison
Compare MSPR & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSPR
- EVGN
- Stock Information
- Founded
- MSPR 2014
- EVGN 1999
- Country
- MSPR United States
- EVGN Israel
- Employees
- MSPR N/A
- EVGN N/A
- Industry
- MSPR
- EVGN Agricultural Chemicals
- Sector
- MSPR
- EVGN Industrials
- Exchange
- MSPR NYSE
- EVGN Nasdaq
- Market Cap
- MSPR 7.8M
- EVGN 7.3M
- IPO Year
- MSPR N/A
- EVGN N/A
- Fundamental
- Price
- MSPR $1.23
- EVGN $1.28
- Analyst Decision
- MSPR
- EVGN Strong Buy
- Analyst Count
- MSPR 0
- EVGN 1
- Target Price
- MSPR N/A
- EVGN $3.50
- AVG Volume (30 Days)
- MSPR 47.6K
- EVGN 5.5M
- Earning Date
- MSPR 08-13-2025
- EVGN 08-21-2025
- Dividend Yield
- MSPR N/A
- EVGN N/A
- EPS Growth
- MSPR N/A
- EVGN N/A
- EPS
- MSPR N/A
- EVGN N/A
- Revenue
- MSPR $13,085,000.00
- EVGN $6,765,000.00
- Revenue This Year
- MSPR N/A
- EVGN N/A
- Revenue Next Year
- MSPR N/A
- EVGN $113.18
- P/E Ratio
- MSPR N/A
- EVGN N/A
- Revenue Growth
- MSPR 34.74
- EVGN N/A
- 52 Week Low
- MSPR $1.10
- EVGN $0.95
- 52 Week High
- MSPR $13.50
- EVGN $7.19
- Technical
- Relative Strength Index (RSI)
- MSPR N/A
- EVGN 47.33
- Support Level
- MSPR N/A
- EVGN $1.34
- Resistance Level
- MSPR N/A
- EVGN $1.63
- Average True Range (ATR)
- MSPR 0.00
- EVGN 0.16
- MACD
- MSPR 0.00
- EVGN -0.02
- Stochastic Oscillator
- MSPR 0.00
- EVGN 15.56
About MSPR MSP RECOVERY INC
MSP Recovery Inc is a healthcare recovery and data analytics company. The business model includes two principal lines of business: Claims Recovery and Chase to Pay Services. It offers an antiquated healthcare reimbursement system with data-driven solutions to secure recoveries against responsible parties. MSP Recovery provides the healthcare industry with comprehensive compliance solutions platform to recover any claims where the law places primary payment responsibility on another payer.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.